Reagent kit for the detection of DNA of human papillomaviruses of high oncogenic risk by polymerase chain reaction (HPV-GEN-16/18) according to TU 9398-008-46482062-2008 in the following versions: 1. Human papillomaviruses of 16.18 types (HPV 16.18). PCR with detection in the mode Real-time: a) Packing S, strips - Amplification mixture sealed with paraffin. Human papillomavirus type 16 (HPV 16) - 12 strips of 8 tubes (20 μl each); - Amplification mixture sealed with paraffin. Human papillomavirus type 18 (HPV 18) - 12 strips of 8 tubes (20 μl each); - Taq polymerase solution - 4 tubes (500 μl each); - Mineral oil - 4 test tubes (1.0 ml each); - Positive HPV 16 control sample - 1 tube (130 μL); - Positive HPV 18 control sample - 1 tube (130 μL); - Strip lids - 24 pcs. b) Filling S, tubes - Amplification mixture sealed with paraffin. Human papillomavirus type 16 (HPV 16) - 96 tubes (20 μl each); - Amplification mixture sealed with paraffin. Human papillomavirus type 18 (HPV 18) - 96 tubes (20 μl each); - Taq polymerase solution - 4 tubes (500 μl each); - Mineral oil - 4 test tubes (1.0 ml each); - Positive control sample HPV 16-1 tube (130 μL); - Positive control sample HPV 18-1 tube (130 μL). 2. Human papillomaviruses of 16.18 types (HPV 16.18). PCR with fluorescence endpoint detection: a) Filling S, 0.5 ml tubes - Amplification mixture sealed with paraffin. Human papillomavirus type 16 (HPV 16) - 100 tubes (20 μl each); - Amplification mixture sealed with paraffin. Human papillomavirus type 18 (HPV 18) - 100 tubes (20 μl each); - Taq polymerase solution - 4 tubes (500 μl each); - PCR buffer (background) - 2 tubes (200 μl); - Mineral oil - 4 test tubes (1.0 ml each); - Positive HPV 16 control sample - 1 tube (130 μL); - Positive control sample HPV 18-1 tube (130 μL). b) Packing S, 0.2 ml tubes - Amplification mixture sealed with paraffin. Human papillomavirus type 16 (HPV 16) - 100 tubes (20 μl each); - Amplification mixture sealed with paraffin. Human papillomavirus type 18 (HPV 18) - 100 tubes (20 μl each); - Taq polymerase solution - 4 tubes (500 μl each); - PCR buffer (background) - 2 tubes (200 μl); - Mineral oil - 4 test tubes (1.0 ml each); , - Positive control sample HPV 16-1 tube (130 μL); - Positive control sample HPV 18-1 tube (130 μL). 3. Human papillomaviruses of 16,18 types (HPV 16,18). PCR with gelelectrophoresis detection: Packaging S Amplification mixture sealed with paraffin. Human papillomavirus type 16 (HPV 16) - 100 tubes (20 μl each); - Amplification mixture sealed with paraffin. Human papillomavirus type 18 (HPV 18) - 100 tubes (20 μl each); - Taq polymerase solution - 4 tubes (500 μl each); - Mineral oil - 4 test tubes (1.0 ml each); - Positive control sample HPV 16-1 tube (130 μL); - Positive control sample HPV 18-1 tube (130 μL); 4. Human papillomavirus type 16 (HPV 16). PCR with real-time detection Time: a) Packing S, strips - Amplification mixture sealed with paraffin - 12 strips of 8 tubes (20 μl each); - Taq polymerase solution - 2 tubes (500 μl each); - Mineral oil - 2 test tubes (1.0 ml each); - Positive control sample - 1 tube (130 μl); - Strip lids - 24 pcs. b) Filling S, tubes - Amplification mixture sealed with paraffin - 96 tubes (20 μl each); - Taq polymerase solution - 2 tubes (500 μl each); - Mineral oil - 2 test tubes (1.0 ml each); - Positive control sample - 1 tube (130 μl). c) Packaging W - Amplification mixture - 2 tubes (1.0 ml each); - Taq polymerase solution - 2 tubes (500 μl each); - Mineral oil - 2 test tubes (1.0 ml each); - Paraffin - 2 tubes (1.0 ml each); - Positive control sample - 1 tube (130 μl). d) Packaging U Amplification mixture - 1 tube (600 μl); - Polymerase TexnoTaq MAX - 1 tube (30 μl); - PCR buffer - 1 tube (600 μl); - Positive control sample - 1 tube (130 μl). 5. Human papillomavirus type 18 (HPV 18). PCR with real-time detection Time: a) Packing S, strips - Paraffin-sealed amplification mixture - 12 strips of 8 tubes (20 μl); - Taq polymerase solution - 2 tubes (500 μl each); - Mineral oil - 2 test tubes (1.0 ml each); - Positive control sample - 1 tube (130 μl); - Strip lids - 24 pcs. b) Filling S, tubes - Amplification mixture sealed with paraffin - 96 tubes (20 μl each); - Taq polymerase solution - 2 tubes (500 μl each); - Mineral oil - 2 test tubes (1.0 ml each); - Positive control sample - 1 tube (130 μL). c) Packaging W - Amplification mixture - 2 tubes (1.0 ml each); - Taq polymerase solution - 2 tubes (500 μl each); - Mineral oil - 2 test tubes (1.0 ml each); - Paraffin - 2 tubes (1.0 ml each); - Positive control sample - 1 tube (130 μL). d) Packaging U - Amplification mixture - 1 tube (600 μl); - Polymerase TexnoTaq MAX - 1 tube (30 μl); - PCR buffer - 1 tube (600 μl); - Positive control sample - 1 tube (130 μL). Place of production: 1. DNA-Technology TS LLC, 20, bldg. 4, Moscow, 117246, Russia. 2. NPO DNA-Technology LLC, Protvino, Moscow Region, 142281, Russia, Zheleznodorozhnaya St., 3. - Roszdravnadzor Registration ФСР 2008/03845
Access comprehensive regulatory information for Reagent kit for the detection of DNA of human papillomaviruses of high oncogenic risk by polymerase chain reaction (HPV-GEN-16/18) according to TU 9398-008-46482062-2008 in the following versions: 1. Human papillomaviruses of 16.18 types (HPV 16.18). PCR with detection in the mode Real-time: a) Packing S, strips - Amplification mixture sealed with paraffin. Human papillomavirus type 16 (HPV 16) - 12 strips of 8 tubes (20 μl each); - Amplification mixture sealed with paraffin. Human papillomavirus type 18 (HPV 18) - 12 strips of 8 tubes (20 μl each); - Taq polymerase solution - 4 tubes (500 μl each); - Mineral oil - 4 test tubes (1.0 ml each); - Positive HPV 16 control sample - 1 tube (130 μL); - Positive HPV 18 control sample - 1 tube (130 μL); - Strip lids - 24 pcs. b) Filling S, tubes - Amplification mixture sealed with paraffin. Human papillomavirus type 16 (HPV 16) - 96 tubes (20 μl each); - Amplification mixture sealed with paraffin. Human papillomavirus type 18 (HPV 18) - 96 tubes (20 μl each); - Taq polymerase solution - 4 tubes (500 μl each); - Mineral oil - 4 test tubes (1.0 ml each); - Positive control sample HPV 16-1 tube (130 μL); - Positive control sample HPV 18-1 tube (130 μL). 2. Human papillomaviruses of 16.18 types (HPV 16.18). PCR with fluorescence endpoint detection: a) Filling S, 0.5 ml tubes - Amplification mixture sealed with paraffin. Human papillomavirus type 16 (HPV 16) - 100 tubes (20 μl each); - Amplification mixture sealed with paraffin. Human papillomavirus type 18 (HPV 18) - 100 tubes (20 μl each); - Taq polymerase solution - 4 tubes (500 μl each); - PCR buffer (background) - 2 tubes (200 μl); - Mineral oil - 4 test tubes (1.0 ml each); - Positive HPV 16 control sample - 1 tube (130 μL); - Positive control sample HPV 18-1 tube (130 μL). b) Packing S, 0.2 ml tubes - Amplification mixture sealed with paraffin. Human papillomavirus type 16 (HPV 16) - 100 tubes (20 μl each); - Amplification mixture sealed with paraffin. Human papillomavirus type 18 (HPV 18) - 100 tubes (20 μl each); - Taq polymerase solution - 4 tubes (500 μl each); - PCR buffer (background) - 2 tubes (200 μl); - Mineral oil - 4 test tubes (1.0 ml each); , - Positive control sample HPV 16-1 tube (130 μL); - Positive control sample HPV 18-1 tube (130 μL). 3. Human papillomaviruses of 16,18 types (HPV 16,18). PCR with gelelectrophoresis detection: Packaging S Amplification mixture sealed with paraffin. Human papillomavirus type 16 (HPV 16) - 100 tubes (20 μl each); - Amplification mixture sealed with paraffin. Human papillomavirus type 18 (HPV 18) - 100 tubes (20 μl each); - Taq polymerase solution - 4 tubes (500 μl each); - Mineral oil - 4 test tubes (1.0 ml each); - Positive control sample HPV 16-1 tube (130 μL); - Positive control sample HPV 18-1 tube (130 μL); 4. Human papillomavirus type 16 (HPV 16). PCR with real-time detection Time: a) Packing S, strips - Amplification mixture sealed with paraffin - 12 strips of 8 tubes (20 μl each); - Taq polymerase solution - 2 tubes (500 μl each); - Mineral oil - 2 test tubes (1.0 ml each); - Positive control sample - 1 tube (130 μl); - Strip lids - 24 pcs. b) Filling S, tubes - Amplification mixture sealed with paraffin - 96 tubes (20 μl each); - Taq polymerase solution - 2 tubes (500 μl each); - Mineral oil - 2 test tubes (1.0 ml each); - Positive control sample - 1 tube (130 μl). c) Packaging W - Amplification mixture - 2 tubes (1.0 ml each); - Taq polymerase solution - 2 tubes (500 μl each); - Mineral oil - 2 test tubes (1.0 ml each); - Paraffin - 2 tubes (1.0 ml each); - Positive control sample - 1 tube (130 μl). d) Packaging U Amplification mixture - 1 tube (600 μl); - Polymerase TexnoTaq MAX - 1 tube (30 μl); - PCR buffer - 1 tube (600 μl); - Positive control sample - 1 tube (130 μl). 5. Human papillomavirus type 18 (HPV 18). PCR with real-time detection Time: a) Packing S, strips - Paraffin-sealed amplification mixture - 12 strips of 8 tubes (20 μl); - Taq polymerase solution - 2 tubes (500 μl each); - Mineral oil - 2 test tubes (1.0 ml each); - Positive control sample - 1 tube (130 μl); - Strip lids - 24 pcs. b) Filling S, tubes - Amplification mixture sealed with paraffin - 96 tubes (20 μl each); - Taq polymerase solution - 2 tubes (500 μl each); - Mineral oil - 2 test tubes (1.0 ml each); - Positive control sample - 1 tube (130 μL). c) Packaging W - Amplification mixture - 2 tubes (1.0 ml each); - Taq polymerase solution - 2 tubes (500 μl each); - Mineral oil - 2 test tubes (1.0 ml each); - Paraffin - 2 tubes (1.0 ml each); - Positive control sample - 1 tube (130 μL). d) Packaging U - Amplification mixture - 1 tube (600 μl); - Polymerase TexnoTaq MAX - 1 tube (30 μl); - PCR buffer - 1 tube (600 μl); - Positive control sample - 1 tube (130 μL). Place of production: 1. DNA-Technology TS LLC, 20, bldg. 4, Moscow, 117246, Russia. 2. NPO DNA-Technology LLC, Protvino, Moscow Region, 142281, Russia, Zheleznodorozhnaya St., 3. in the Russia medical device market through Pure Global AI's free database. This Class 2b medical device is registered under Roszdravnadzor registration number ФСР 2008/03845 and manufactured by DNA-Technology TS LLC. The device was registered on August 08, 2024.
This page provides complete registration details including device type, manufacturer information, country of origin (Russia), and regulatory compliance data from the official Russia Roszdravnadzor medical device database. Pure Global AI offers free access to Russia's complete medical device registry, helping global MedTech companies navigate Roszdravnadzor regulations efficiently.

